These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 11387803)

  • 1. Ophthalmic manifestations of HIV: an update.
    DeGrezia MG; Robinson M
    J Assoc Nurses AIDS Care; 2001; 12(3):22-32. PubMed ID: 11387803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytomegalovirus retinitis in the era of highly active antiretroviral therapy.
    Kedhar SR; Jabs DA
    Herpes; 2007 Dec; 14(3):66-71. PubMed ID: 18371289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ophthalmic manifestations of HIV in the highly active anti-retroviral therapy era.
    Mowatt L
    West Indian Med J; 2013; 62(4):305-12. PubMed ID: 24756590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of immune recovery uveitis in patients with AIDS and cytomegalovirus retinitis.
    Kempen JH; Min YI; Freeman WR; Holland GN; Friedberg DN; Dieterich DT; Jabs DA;
    Ophthalmology; 2006 Apr; 113(4):684-94. PubMed ID: 16581429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN; Vaudaux JD; Shiramizu KM; Yu F; Goldenberg DT; Gupta A; Carlson M; Read RW; Novack RD; Kuppermann BD;
    Am J Ophthalmol; 2008 Jan; 145(1):12-22. PubMed ID: 18154751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new acronym, a new threat: IRU.
    Proj Inf Perspect; 1999 Sep; (28):11. PubMed ID: 11367354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ocular manifestations of AIDS: new considerations for patients using highly active anti-retroviral therapy (HAART).
    Roels P
    Optometry; 2004 Oct; 75(10):624-8. PubMed ID: 15508863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytomegalovirus retinitis and immune recovery uveitis in AIDS patients treated with highly active antiretroviral therapy in Taiwanese.
    Lin YC; Yang CH; Lin CP; Yang CM; Chen MS; Chen MY; Sheng WH; Hung CC; Chang SC
    Ocul Immunol Inflamm; 2008; 16(3):83-7. PubMed ID: 18569793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uveitis as an initial manifestation of acquired immunodeficiency syndrome.
    Tsen CL; Chen SC; Chen YS; Sheu SJ
    Int J STD AIDS; 2017 Oct; 28(12):1224-1228. PubMed ID: 28201950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human immunodeficiency virus and intraocular inflammation in the era of highly active anti retroviral therapy - An update.
    Sudharshan S; Nair N; Curi A; Banker A; Kempen JH
    Indian J Ophthalmol; 2020 Sep; 68(9):1787-1798. PubMed ID: 32823395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ophthalmic manifestations of HIV infections in India in the era of HAART: analysis of 100 consecutive patients evaluated at a tertiary eye care center in India.
    Gharai S; Venkatesh P; Garg S; Sharma SK; Vohra R
    Ophthalmic Epidemiol; 2008; 15(4):264-71. PubMed ID: 18780260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of cytomegalovirus (CMV) retinitis in second eyes of patients with the acquired immune deficiency syndrome and unilateral CMV retinitis.
    Kempen JH; Jabs DA; Wilson LA; Dunn JP; West SK
    Am J Ophthalmol; 2005 Jun; 139(6):1028-34. PubMed ID: 15953432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The epidemiology, treatment patterns, and costs of cytomegalovirus retinitis in the post-haart era among a national managed-care population.
    Mahadevia PJ; Gebo KA; Pettit K; Dunn JP; Covington MT
    J Acquir Immune Defic Syndr; 2004 Aug; 36(4):972-7. PubMed ID: 15220705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytomegalovirus retinitis in the era of combined highly active antiretroviral therapy.
    See RF; Rao NA
    Ophthalmol Clin North Am; 2002 Dec; 15(4):529-36, viii. PubMed ID: 12515085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Current strategies for treatment of CMV retinitis in patients with AIDS].
    Lüke C; Bartz-Schmidt KU; Walter P; Heimann K
    Klin Monbl Augenheilkd; 1999 Jul; 215(1):4-9. PubMed ID: 10448631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is cytomegalovirus viraemia a useful tool in managing CMV disease?
    Deayton JR
    Sex Transm Infect; 2000 Oct; 76(5):342-4. PubMed ID: 11141848
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical characteristics and outcomes of cytomegalovirus retinitis in persons without human immunodeficiency virus infection.
    Kuo IC; Kempen JH; Dunn JP; Vogelsang G; Jabs DA
    Am J Ophthalmol; 2004 Sep; 138(3):338-46. PubMed ID: 15364214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of Cytomegalovirus Retinitis in HIV and Non-HIV Patients.
    Pearce WA; Yeh S; Fine HF
    Ophthalmic Surg Lasers Imaging Retina; 2016 Feb; 47(2):103-7. PubMed ID: 26878441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [CMV retinitis--"the lightning that announces a storm"].
    Gafencu O; Cârstocea B; Ioniţă M
    Oftalmologia; 1998; 45(4):14-20. PubMed ID: 10418623
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven years of HAART impact on ophthalmic management of HIV-infected patients.
    Kahraman G; Krepler K; Franz C; Ries E; Maar N; Wedrich A; Rieger A; Dejaco-Ruhswurm I
    Ocul Immunol Inflamm; 2005; 13(2-3):213-8. PubMed ID: 16019681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.